Anders Österborg, M.D. Karolinska University Hospital (Sweden)

Dr. Anders Österborg is Professor of Oncology at the Karolinska Hospital and Institute in Stockholm, Sweden. His main areas of research are immunology and immunotherapy of lymphoid malignancies, including chronic lymphocytic leukemia, multiple myeloma and non-Hodgkin's lymphoma. His research explores the characteristics and immune regulation of the tumor clone in B-cell lymphoproliferative diseases and is actively involved in the development of immunotherapeutics, including monoclonal antibody therapy, tumor vaccines, and small molecules in a translational setting. He is also involved in anemia research in these disorders and the development of erythropoiesis-stimulating agents and their optimal use.

Dr. Österborg has been principal investigator in numerous international collaborative clinical trials. He has lectured extensively at international conferences and has organized several international CME courses that discuss the role of immunotherapy in treating lymphoproliferative disorders. He is the head of the haematology branch of the Karolinska Institute Cancer (KIC) network. He has published more than 195 original research articles and textbook chapters in the areas of hematology and oncology, and he is the editor of Medical Oncology.